Biomarkers like nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and oxidative stress markers (e.g., malondialdehyde) are gaining attention for their utility in early neuropathy detection. This evidence concerns the gene NGF and neuropathy.